194 related articles for article (PubMed ID: 22776935)
1. Bevacizumab therapy for tamoxifen-induced crystalline retinopathy and severe cystoid macular edema.
Rahimy E; Sarraf D
Arch Ophthalmol; 2012 Jul; 130(7):931-2. PubMed ID: 22776935
[No Abstract] [Full Text] [Related]
2. Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.
Bourla DH; Sarraf D; Schwartz SD
Am J Ophthalmol; 2007 Jul; 144(1):126-8. PubMed ID: 17601434
[TBL] [Abstract][Full Text] [Related]
3. Spectral domain optical coherence tomography predictors of visual outcome in diabetic cystoid macular edema after bevacizumab injection.
Al Faran A; Mousa A; Al Shamsi H; Al Gaeed A; Ghazi NG
Retina; 2014 Jun; 34(6):1208-15. PubMed ID: 24368308
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal fasudil combined with bevacizumab for persistent diabetic macular edema: a novel treatment.
Ahmadieh H; Nourinia R; Hafezi-Moghadam A
JAMA Ophthalmol; 2013 Jul; 131(7):923-4. PubMed ID: 23640178
[No Abstract] [Full Text] [Related]
5. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.
Kim M; Lee P; Kim Y; Yu SY; Kwak HW
Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008
[TBL] [Abstract][Full Text] [Related]
7. Combined bevacizumab and triamcinolone acetonide injections for macular edema in a patient with astrocytic hamartomas and tuberous sclerosis.
Lonngi M; Gold AS; Murray TG
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(1):85-90. PubMed ID: 23410814
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen retinopathy: A comprehensive review.
Tenney S; Oboh-Weilke A; Wagner D; Chen MY
Surv Ophthalmol; 2024; 69(1):42-50. PubMed ID: 37482306
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of pseudophakic cystoid macular edema with intravitreal bevacizumab.
Barone A; Prascina F; Russo V; Iaculli C; Primavera V; Querques G; Stella A; Delle Noci N
J Cataract Refract Surg; 2008 Jul; 34(7):1210-2. PubMed ID: 18571091
[TBL] [Abstract][Full Text] [Related]
11. Treatment of macular edema because of occlusive vasculitis with bevacizumab (avastin): efficacy of three consecutive monthly injections.
Nuti E; Traversi C; Marigliani D; Balestrazzi A; Alegente M; Martone G; Malandrini A; Romeo N; Mazzotta C; Tosi GM
Retina; 2011 Oct; 31(9):1863-70. PubMed ID: 21799465
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function.
Munk M; Kiss C; Huf W; Sulzbacher F; Bolz M; Sayegh R; Eisenkölbl S; Simader C; Schmidt-Erfurth U
Retina; 2013 Oct; 33(9):1915-22. PubMed ID: 23584693
[TBL] [Abstract][Full Text] [Related]
13. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab in postoperative pseudophakic cystoid macular edema: does it really work?
Spitzer MS; Szurman P; Bartz-Schmidt KU
J Cataract Refract Surg; 2008 Jun; 34(6):880; author reply 880-1. PubMed ID: 18498977
[No Abstract] [Full Text] [Related]
15. [Treatment of cystoid macular edema with bevacizumab in course of Irvine-Gass syndrome].
Izdebski B; Michalewska Z; Dziegielewski K; Nawrocki J; Odrobina D
Klin Oczna; 2013; 115(1):61-4. PubMed ID: 23882744
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
17. Management of Coats disease with bevacizumab in 2 patients.
Venkatesh P; Mandal S; Garg S
Can J Ophthalmol; 2008 Apr; 43(2):245-6. PubMed ID: 18347637
[No Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms.
Pichi F; Morara M; Torrazza C; Manzi G; Alkabes M; Balducci N; Vitale L; Lembo A; Ciardella AP; Nucci P
Am J Ophthalmol; 2013 Feb; 155(2):287-294.e1. PubMed ID: 23111179
[TBL] [Abstract][Full Text] [Related]
19. Multifocal outer retinopathy in a patient with multifocal inner choroidopathy.
Chen FK; Tufail A
Clin Exp Ophthalmol; 2011; 39(7):700-3. PubMed ID: 22452687
[No Abstract] [Full Text] [Related]
20. Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion.
Yasuda S; Kondo M; Kachi S; Ito Y; Terui T; Ueno S; Terasaki H
Retina; 2011 Jun; 31(6):1075-82. PubMed ID: 21478810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
